Skip to main content
OpenTrials
Completed

NCT Number: NCT04938479

D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure

Cerebral infarction is the leading cause of acquired disability in adults. Absence of biological marker used in current practice and identified as a prognostic factor for recovery. D-dimers are degradation products of stabilized fibrin translating an activation of coagulation whatever the cause. Studies have shown that increased D-dimer levels in patients with MI is associated with a higher mortality rate, the link with post-intervention non-revascularization has been demonstrate.

The purpose of this project is to search for a correlation between the level of D-dimer and the degree of recovery evaluated by the NIHSS score

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 to 65
  • Cerebral infarctions undergoing a revascularization procedure by thrombolysis and / or thrombectomy, at the Amiens University Hospital between January 2015 and December 2020.
  • Patients having benefited from a D-dimer assay (during their stay)

Exclusion criteria

-

Treatment and study plan

Blood sample

Biological

D-dimer measurement in blood sample

Primary outcomes

  1. Correlation between D-dimer concentration and NIHSS score

    Time frame: 3 months

    NIHSS score is based on the clinical neurological examination of the patient. Validated by the scientific community of vascular neurology, among other things in projective clinical research. This score has high inter-observer reproducibility Expressed quantitatively on a scale of 0 to 42 for the NIHSS score A high value of the NIHSS score indicates poor recovery.

  2. Correlation between D-dimer concentration and NIHSS score

    Time frame: 6 months

    NIHSS score is based on the clinical neurological examination of the patient. Validated by the scientific community of vascular neurology, among other things in projective clinical research. This score has high inter-observer reproducibility Expressed quantitatively on a scale of 0 to 42 for the NIHSS score A high value of the NIHSS score indicates poor recovery.

  3. Correlation between D-dimer concentration and the Rankin score

    Time frame: 3 months

    Rankin Scale collected by the neurologist in consultation 3-6 months post stroke.

    Expressed quantitatively on a scale of 0 to 6 for the Rankin scale. A high value of the Rankin scale indicates poor recovery.

  4. Correlation between D-dimer concentration and the Rankin score

    Time frame: 6 months

    Rankin Scale collected by the neurologist in consultation 3-6 months post stroke.

    Expressed quantitatively on a scale of 0 to 6 for the Rankin scale. A high value of the Rankin scale indicates poor recovery.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: D-Dimer

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jun 24, 2021
Registry last updated
Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.